|
[1]SUN DN, HUANG X.Roles and mechanism of NF-κB in hepatocellular carcinoma development[J].China Med Herald, 2016, 13 (18) :42-45. (in Cninese) 孙丹妮, 黄洵.NF-κB在肝细胞癌发生发展中的作用及其机制研究进展[J].中国医药导报, 2016, 13 (18) :42-45.
|
|
[2] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :60-90.
|
|
[3]GRIVENNIKOV SI, GRETEN FR, KARIN M.Immunity, inflammation, and cancer[J].Cell, 2010, 140 (6) :883-899.
|
|
[4]Poon RT.Prevention of recurrence after resection of hepatocellular carcinoma:a daunting challenge[J].Hepatology, 2011, 54 (3) :757-759.
|
|
[5]TRALHAO JG, DAGHER I, LINO T, et al.Treatment of tumour recurrence after resection of hepatocellular carcinoma.Analysis of 97 consecutive patients[J].Eur J Surg Oncol, 2007, 33 (6) :746-751.
|
|
[6]OH BS, JANG JW, KWON JH, et al.Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma[J].BMC Cancer, 2013, 13 (1) :1-9.
|
|
[7]SULLIVAN KM, GROESCHL RT, TURAGA KK, et al.Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma:a Western perspective[J].J Surg Oncol, 2014, 109 (2) :95-97.
|
|
[8]YAMAMURA K, SUGIMOTO H, KANDA M, et al.Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection[J].J Hepatobiliary Pancreat Sci, 2014, 21 (9) :682-688.
|
|
[9]da FONSECA LG, BARROSO-SOUSA R, BENTO ADA S, et al.Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib[J].Med Oncol, 2014, 31 (11) :264.
|
|
[10]GIAKOUSTIDIS A, NEOFYTOU K, KHAN AZ, et al.Neutrophil to lymphocyte ratio predicts pattern of recurrence in patients undergoing liver resection for colorectal liver Metastasis and thus the overall survival[J].J Surg Oncol, 2015, 111 (4) :445-450.
|
|
[11]FAN W, ZHANG Y, WANG Y, et al.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization[J].PLo S One, 2015, 10 (3) :e0119312.
|
|
[12]OKAMURA Y, ASHIDA R, ITO T, et al.Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma[J].World JSurg, 2015, 39 (6) :1501-1509.
|
|
[13]CHEN Q, YANG LX, LI XD, et al.The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy[J].Tumour Biol, 2015, 36 (7) :5283-5289.
|
|
[14]SUKATO DC, TOHME S, CHALHOUB D, et al.The prognostic role of neutrophil-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma treated with radioembolization[J].J Vasc Interv Radiol, 2015, 26 (6) :816-824.e1.
|
|
[15]LU SD, WANG YY, PENG NF, et al.Preoperative ratio of neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinoma[J].Medicine (Baltimore) , 2016, 95 (5) :e2722.
|
|
[16]JI F, LIANG Y, FU SJ, et al.A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection:the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI) [J].BMC Cancer, 2016, 16:137.
|
|
[17]HU XG, MAO W, PARK YK, et al.Blood neutrophil-to-lymphocyte ratio predicts tumor recurrence in patients with hepatocellular carcinoma within milan criteria after hepatectomy[J].Yonsei Med J, 2016, 57 (5) :1115-1123.
|
|
[18]LI YB, ZHANG J, LI GP, et al.Correlation of neutrophil-tolymphocyte ratio with the clinicopathological characteristics and prognosis of early primary hepatocellular carcinoma[J].Tumor, 2016, 36 (7) :784-790. (in Chinese) 李友炳, 张军, 李国平, 等.中性粒细胞/淋巴细胞比值与早期原发性肝细胞癌临床病理特征及预后的相关性[J].肿瘤, 2016, 36 (7) :784-790.
|
|
[19]WANG WJ, ZHAO Y, XIA DD, et al.Predictive value of neutrophil-lymphocyte ratio and its dynamic change in patients with hepatocellular carcinoma undergoing transarterial chemoembolization[J].J Clin Hepatol, 2016, 32 (6) :1139-1144. (in Chinese) 王文军, 赵艳, 夏冬东, 等.中性粒细胞与淋巴细胞比值及其动态变化对经肝动脉化疗栓塞术治疗的肝细胞癌患者预后的预测价值[J].临床肝胆病杂志, 2016, 32 (6) :1139-1144.
|
|
[20]EIR N, VIZOSO FJ.Imflammation and cancer[J].World J Gastrointest Surg, 2012, 4 (3) :62-72.
|
|
[21]HOFMAN PM.Pathobiology of the neutrophil-intestinal epithelial cell interaction:role in carcinogenesis[J].World J Gastroenterol, 2010, 16 (46) :5790-5800.
|
|
[22]ROXBURGH CS, MCMILLAN DC.Role of systemic inflammatory response in predicting survival in patients with primary operable cancer[J].Future Oncology, 2010, 6 (1) :149-163.
|
|
[23]SCONOCCHIA G, EPPENBERGER S, SPAGNOLI GC, et al.NKcells and T cells cooperate during the clinical course of colorectal cancer[J].Oncoimmunology, 2014, 3 (8) :e952197.
|
|
[24]ZHOU WY, ZHANG JP.The association of pre-treatment neutrophil-to-lymphocyte ratios with response of neoadjuvant theropy, clinical outcome in patients with IB2-IIB cervical cancer[J].Clin J Med Offic, 2016, 44 (2) :119-123. (in Chinese) 周文毓, 张建平.IB2-IIB期宫颈癌新辅助化疗治疗前中性粒细胞与淋巴细胞比值对疗效及预后预测意义[J].临床军医杂志, 2016, 44 (2) :119-123.
|
DownLoad: